PRME - Prime Medicine, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
6.01 0.38 (6.32%)	---	---	0.01 (0.16%)	0.19 (3.16%)	0.18 (2.91%)	0.01 (0.14%)	0.01 (0.14%)

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.41
Diluted EPS:: -0.41
Basic P/E:: -15.5854
Diluted P/E:: -15.5854
RSI(14) 1m:: 100.0
VWAP:: 6.39
RVol:: 1.371

Events

Period	Kind	Movement	Occurred At
60m	Price increase 60m	6.25 +0.32 (+5.4%)	Oct 15 17:48
1m	Price increase 1m	6.27 +0.07 (+1.13%)	Oct 15 11:22
10m	Price decrease 10m	6.43 -0.2 (-3.02%)	Oct 15 10:16
Day	Price increase day	6.65 +0.63 (+10.57%)	Oct 15 10:05
1m	Price increase 1m	6.65 +0.11 (+1.68%)	Oct 15 10:05